Prescription drug · ANDA
prednisone NDC 60219-1706
Prednisone 5 mg/1 · Tablet · Oral · Amneal Pharmaceuticals NY LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60219-1706-1 | 60219170601 | 100 TABLET in 1 BOTTLE, PLASTIC (60219-1706-1)Marketed from Aug 4, 2021 | |
| 60219-1706-3 | 60219170603 | 10 BLISTER PACK in 1 CARTON (60219-1706-3) / 10 TABLET in 1 BLISTER PACK (60219-1706-2)Marketed from Aug 4, 2021 | |
| 60219-1706-7 | 60219170607 | 1000 TABLET in 1 BOTTLE, PLASTIC (60219-1706-7)Marketed from Aug 4, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- prednisone
- Generic name (nonproprietary)
- prednisone
- Active ingredients
- Prednisone — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213385
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 60219-1706_abdf7308-9460-4e7f-a68a-2fe647e82602SPL ID abdf7308-9460-4e7f-a68a-2fe647e82602SPL set ID 0740ef68-7641-432e-bd46-4710687fc9d7RxCUI 198144, 312617UNII VB0R961HZTUPC 0360219170513
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N460219170601followed by a unit qualifier and the quantityPackage 60219-1706-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) Ankylosing spondylitis Acute a…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 213385
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| prednisone | Prednisone 5 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-988 |
| prednisone | Prednisone 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7686 |
| prednisone | Prednisone 5 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8439 |
| prednisone | Prednisone 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7684 |
| prednisone | Prednisone 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7688 |
| prednisone | Prednisone 1 mg/1 | TabletOral | Amneal Pharmaceuticals NY LLC | 60219-1705 |